Engineered exosomes for cancer theranostics: Next-generation tumor targeting

[1]  Vivek P. Chavda,et al.  Exosome nanovesicles: A potential carrier for therapeutic delivery , 2023, Nano Today.

[2]  J. Bao,et al.  The CRISPR/Cas9 System Delivered by Extracellular Vesicles , 2023, Pharmaceutics.

[3]  Vivek P. Chavda,et al.  Antibody–Biopolymer Conjugates in Oncology: A Review , 2023, Molecules.

[4]  M. Ahmad,et al.  Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives , 2023, 3 Biotech.

[5]  Vivek P. Chavda,et al.  mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown! , 2023, Vaccines.

[6]  Vivek P. Chavda,et al.  Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer , 2023, Cancers.

[7]  Vivek P. Chavda,et al.  Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer , 2022, Cancers.

[8]  Vivek P. Chavda,et al.  mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics , 2022, Vaccines.

[9]  Vivek P. Chavda,et al.  Nanoparticle-Based Delivery Systems for Vaccines , 2022, Vaccines.

[10]  Vivek P. Chavda,et al.  Successes and failures of immunotherapy for gastric cancer. , 2022, Drug discovery today.

[11]  Vivek P. Chavda,et al.  Lyotropic liquid crystals for parenteral drug delivery. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[12]  R. Mir,et al.  Plant-derived extracellular vesicles: a novel nanomedicine approach with advantages and challenges , 2022, Cell Communication and Signaling.

[13]  Vivek P. Chavda,et al.  Convalescent serum-derived exosomes: Attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery , 2022, Experimental biology and medicine.

[14]  C. Heldin,et al.  Extracellular Vesicles and Transforming Growth Factor β Signaling in Cancer , 2022, Frontiers in Cell and Developmental Biology.

[15]  Vivek P. Chavda,et al.  An Ayurgenomics Approach: Prakriti-Based Drug Discovery and Development for Personalized Care , 2022, Frontiers in Pharmacology.

[16]  Vivek P. Chavda,et al.  Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges , 2022, Frontiers in Oncology.

[17]  Vivek P. Chavda,et al.  Phytochemical-loaded liposomes for anticancer therapy: an updated review. , 2022, Nanomedicine.

[18]  Suwen Bai,et al.  Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis , 2022, Frontiers in Cell and Developmental Biology.

[19]  Vivek P. Chavda,et al.  Phytochemical Delivery Through Transferosome (Phytosome): An Advanced Transdermal Drug Delivery for Complementary Medicines , 2022, Frontiers in Pharmacology.

[20]  E. Chowdhury,et al.  Active targeting via ligand-anchored pH-responsive strontium nanoparticles for efficient nucleic acid delivery into breast cancer cells , 2022, Journal of Pharmaceutical Investigation.

[21]  Jiannan Li,et al.  Mesenchymal stem cell-derived exosomes for gastrointestinal cancer , 2021, World journal of gastrointestinal oncology.

[22]  L. Ji,et al.  Engineered exosomes as a natural nanoplatform for cancer targeted delivery of metal-based drugs , 2021, Coordination Chemistry Reviews.

[23]  So Yeon Jeong,et al.  Canine Natural Killer Cell-Derived Exosomes Exhibit Antitumor Activity in a Mouse Model of Canine Mammary Tumor , 2021, BioMed research international.

[24]  Ying Zheng,et al.  Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies , 2021, Theranostics.

[25]  V. LeBleu,et al.  Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer , 2021, Life Science Alliance.

[26]  Hong-Wei Sun,et al.  Near infrared light fluorescence imaging-guided biomimetic nanoparticles of extracellular vesicles deliver indocyanine green and paclitaxel for hyperthermia combined with chemotherapy against glioma , 2021, Journal of Nanobiotechnology.

[27]  M. Malim,et al.  Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study , 2021, The Lancet Oncology.

[28]  D. Perocheau,et al.  The exosome journey: from biogenesis to uptake and intracellular signalling , 2021, Cell communication and signaling : CCS.

[29]  Kezhen Yi,et al.  Aptamer-Exosomes for Tumor Theranostics. , 2021, ACS sensors.

[30]  Li Duan,et al.  Engineering exosomes for targeted drug delivery , 2021, Theranostics.

[31]  A. Hashemi,et al.  The Emerging Role of Exosomes as Cancer Theranostics , 2021, Nanotechnology in the Life Sciences.

[32]  R. Cortes,et al.  Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus , 2020, Pharmaceutics.

[33]  Yin Xiao,et al.  Exosome-mediated delivery of gene vectors for gene therapy. , 2020, Nanoscale.

[34]  S. Ostad,et al.  Exosomes derived from miR-34a-overexpressing mesenchymal stem cells inhibit in vitro tumor growth: A new approach for drug delivery. , 2020, Life sciences.

[35]  X. Hua,et al.  Exosomal miR-499a-5p Inhibits Endometrial Cancer Growth and Metastasis via Targeting VAV3 , 2020, Cancer management and research.

[36]  F. Lai,et al.  Exosomes and Extracellular Vesicles as Emerging Theranostic Platforms in Cancer Research , 2020, Cells.

[37]  Xuemei Wang,et al.  Efficient encapsulation of biocompatible nanoparticles in exosomes for cancer theranostics , 2020 .

[38]  R. Hass,et al.  Anti-Tumor Effects of Exosomes Derived from Drug-Incubated Permanently Growing Human MSC , 2020, International journal of molecular sciences.

[39]  S. Du,et al.  Exosome: A Review of Its Classification, Isolation Techniques, Storage, Diagnostic and Targeted Therapy Applications , 2020, International journal of nanomedicine.

[40]  Y. Tao,et al.  Exosomes: key players in cancer and potential therapeutic strategy , 2020, Signal Transduction and Targeted Therapy.

[41]  Minchen Liu,et al.  The Antitumor Effect of Gene-Engineered Exosomes in the Treatment of Brain Metastasis of Breast Cancer , 2020, Frontiers in Oncology.

[42]  Yuhua Wei,et al.  Anticancer effects of miR-124 delivered by BM-MSC derived exosomes on cell proliferation, epithelial mesenchymal transition, and chemotherapy sensitivity of pancreatic cancer cells , 2020, Aging.

[43]  J. McKiernan,et al.  Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2–10 ng/mL , 2020, Prostate Cancer and Prostatic Diseases.

[44]  A. Arbab,et al.  Generation of Novel Diagnostic and Therapeutic Exosomes to Detect and Deplete Protumorigenic M2 Macrophages , 2020, Advanced therapeutics.

[45]  Thean-Hock Tang,et al.  Strategies to bioengineer aptamer-driven nanovehicles as exceptional molecular tools for targeted therapeutics: A review. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[46]  K. Seong,et al.  The Emerging Roles of Exosomes as EMT Regulators in Cancer , 2020, Cells.

[47]  A. Alexandrova,et al.  Proteomic Analysis of Blood Exosomes from Healthy Females and Breast Cancer Patients Reveals an Association between Different Exosomal Bioactivity on Non-tumorigenic Epithelial Cell and Breast Cancer Cell Migration in Vitro , 2020, Biomolecules.

[48]  S. Hosseinimehr,et al.  99mTc-radiolabeled HER2 targeted exosome for tumor imaging. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[49]  G. Cai,et al.  Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation , 2020, Nature Communications.

[50]  H. Santos,et al.  Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach , 2020 .

[51]  K. Cheng,et al.  Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs , 2020, Theranostics.

[52]  Qingdong Guo,et al.  Exosomal Sonic Hedgehog derived from cancer‐associated fibroblasts promotes proliferation and migration of esophageal squamous cell carcinoma , 2020, Cancer medicine.

[53]  Guodong Yang,et al.  Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium , 2020, Theranostics.

[54]  Q. Luo,et al.  Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells , 2019, Asian journal of pharmaceutical sciences.

[55]  Xiaodong Xie,et al.  Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer. , 2019, Nanoscale.

[56]  Yuan Yuan,et al.  Tumor-specific delivery of KRAS siRNA with iRGD-exosomes efficiently inhibits tumor growth , 2019 .

[57]  Betty Y. S. Kim,et al.  Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation , 2019, Nature Biomedical Engineering.

[58]  F. Pociot,et al.  Breast Milk-Derived Extracellular Vesicles Enriched in Exosomes From Mothers With Type 1 Diabetes Contain Aberrant Levels of microRNAs , 2019, Front. Immunol..

[59]  Dong Zhang,et al.  Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN , 2019, Medical science monitor basic research.

[60]  Weilei Hu,et al.  Cocktail Strategy Based on NK Cell-Derived Exosomes and Their Biomimetic Nanoparticles for Dual Tumor Therapy , 2019, Cancers.

[61]  Zhenjie Liu,et al.  Involvement of macrophage-derived exosomes in abdominal aortic aneurysms development. , 2019, Atherosclerosis.

[62]  C. Xiong,et al.  Copper-64 Labeled PEGylated Exosomes for In Vivo Positron Emission Tomography and Enhanced Tumor Retention. , 2019, Bioconjugate chemistry.

[63]  Jeremy G. Carlton,et al.  The ESCRT-machinery: closing holes and expanding roles. , 2019, Current opinion in cell biology.

[64]  A. Sahebkar,et al.  The therapeutic and diagnostic role of exosomes in cardiovascular diseases. , 2019, Trends in cardiovascular medicine.

[65]  Asier Unciti-Broceta,et al.  Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis , 2019, Nature Catalysis.

[66]  Xiao Yue,et al.  Hypoxic Glioma Cell-Secreted Exosomal miR-301a Activates Wnt/β-catenin Signaling and Promotes Radiation Resistance by Targeting TCEAL7. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[67]  Haiyan Li,et al.  The malignant role of exosomes in the communication among colorectal cancer cell, macrophage and microbiome. , 2019, Carcinogenesis.

[68]  U. Ruktanonchai,et al.  Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood–brain barrier penetration , 2019, Scientific Reports.

[69]  R. Hass,et al.  Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells , 2019, Cancers.

[70]  A. Agrawal,et al.  Milk exosomes - Natural nanoparticles for siRNA delivery. , 2019, Cancer letters.

[71]  Dihua Yu,et al.  Exosomes in cancer development, metastasis, and immunity. , 2019, Biochimica et biophysica acta. Reviews on cancer.

[72]  R. Kalluri,et al.  Mechanisms associated with biogenesis of exosomes in cancer , 2019, Molecular Cancer.

[73]  C. Blanpain,et al.  EMT Transition States during Tumor Progression and Metastasis. , 2019, Trends in cell biology.

[74]  H. Leong,et al.  The role of extracellular vesicles in cancer microenvironment and metastasis: myths and challenges. , 2019, Biochemical Society transactions.

[75]  Kanyi Pu,et al.  Near-Infrared Afterglow Semiconducting Nano-Polycomplexes for the Multiplex Differentiation of Cancer Exosomes. , 2019, Angewandte Chemie.

[76]  Y. Zhang,et al.  Exosomes: biogenesis, biologic function and clinical potential , 2019, Cell & Bioscience.

[77]  Jun Wang,et al.  miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC , 2019, Cell Death & Disease.

[78]  Haifeng Dong,et al.  Engineered Exosome-Mediated Near-Infrared-II Region V2C Quantum Dot Delivery for Nucleus-Target Low-Temperature Photothermal Therapy. , 2019, ACS nano.

[79]  Xiaojing Liu,et al.  Aptamer-Functionalized Exosomes: Elucidating the Cellular Uptake Mechanism and the Potential for Cancer-Targeted Chemotherapy. , 2019, Analytical chemistry.

[80]  G. Ananda,et al.  Technical and Regulatory Considerations for Taking Liquid Biopsy to the Clinic: Validation of the JAX PlasmaMonitorTM Assay , 2019, Biomarker insights.

[81]  Rajashekhar Kanchanapally,et al.  Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis , 2019, International journal of nanomedicine.

[82]  A. Anel,et al.  Role of Exosomes in the Regulation of T-Cell Mediated Immune Responses and in Autoimmune Disease , 2018, Cells.

[83]  Guodong Yang,et al.  In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized Exosomes Encapsulated with miRNA or CRISPR/dCas9. , 2018, Nano letters.

[84]  M. DiFiglia,et al.  Exosomes Produced from 3D Cultures of MSCs by Tangential Flow Filtration Show Higher Yield and Improved Activity. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[85]  A. Khan,et al.  Recent progress of drug nanoformulations targeting to brain , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[86]  Q. Shu,et al.  Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs , 2018, Stem Cell Research & Therapy.

[87]  Baoan Chen,et al.  Nano in nano: Biosynthesized gold and iron nanoclusters cargo neoplastic exosomes for cancer status biomarking. , 2018, Nanomedicine : nanotechnology, biology, and medicine.

[88]  Chun-Ming Huang,et al.  Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway , 2018, Journal of experimental & clinical cancer research : CR.

[89]  Peixuan Guo,et al.  Arrowtail RNA for Ligand Display on Ginger Exosome-like Nanovesicles to Systemic Deliver siRNA for Cancer Suppression , 2018, Scientific Reports.

[90]  David W. Greening,et al.  Extracellular vesicles in cancer — implications for future improvements in cancer care , 2018, Nature Reviews Clinical Oncology.

[91]  Lei Huang,et al.  Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1 , 2018, Oncogene.

[92]  X. Tan,et al.  Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer , 2018, Cancer science.

[93]  Q. Tang,et al.  NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. , 2018, Biomaterials.

[94]  Wei Zhang,et al.  Exosomal PD-L1 Contributes to Immunosuppression and is Associated with anti-PD-1 Response , 2018, Nature.

[95]  Mengsu Yang,et al.  Efficient RNA drug delivery using red blood cell extracellular vesicles , 2018, Nature Communications.

[96]  H. Iinuma,et al.  Exosome-encapsulated microRNA-223-3p as a minimally invasive biomarker for the early detection of invasive breast cancer. , 2018, Oncology letters.

[97]  Li Yang,et al.  Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer , 2018, Molecular Cancer.

[98]  Dan Peer,et al.  Progress and challenges towards targeted delivery of cancer therapeutics , 2018, Nature Communications.

[99]  Vishnu Ramachandran,et al.  Horizontal transfer of miR‐23a from hypoxic tumor cell colonies can induce angiogenesis , 2018, Journal of cellular physiology.

[100]  P. Dong,et al.  Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E , 2018, Cell Death & Disease.

[101]  S. Caja,et al.  Exosome-Based Cell-Cell Communication in the Tumor Microenvironment , 2018, Front. Cell Dev. Biol..

[102]  Nam-Trung Nguyen,et al.  Biological Functions and Current Advances in Isolation and Detection Strategies for Exosome Nanovesicles. , 2018, Small.

[103]  Yanliang Zhu,et al.  Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells , 2018, International journal of nanomedicine.

[104]  Graça Raposo,et al.  Shedding light on the cell biology of extracellular vesicles , 2018, Nature Reviews Molecular Cell Biology.

[105]  Saheli Samanta,et al.  Exosomes: new molecular targets of diseases , 2017, Acta Pharmacologica Sinica.

[106]  T. Whiteside.  Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. , 2017, Seminars in immunology.

[107]  J. Hung,et al.  Hypoxic Lung-Cancer-Derived Extracellular Vesicle MicroRNA-103a Increases the Oncogenic Effects of Macrophages by Targeting PTEN , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[108]  Bing Chen,et al.  exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes , 2017, Nucleic Acids Res..

[109]  P. Shang,et al.  Transferrin receptor 1 in cancer: a new sight for cancer therapy. , 2018, American journal of cancer research.

[110]  Yanning Liu,et al.  Exosomal proteins as potential markers of tumor diagnosis , 2017, Journal of Hematology & Oncology.

[111]  Muller Fabbri,et al.  Biological roles and potential applications of immune cell-derived extracellular vesicles , 2017, Journal of extracellular vesicles.

[112]  L. Parker,et al.  Exosomal delivery of berry anthocyanidins for the management of ovarian cancer. , 2017, Food & function.

[113]  R. Khokha,et al.  Metalloproteinases in extracellular vesicles. , 2017, Biochimica et biophysica acta. Molecular cell research.

[114]  E. Walters,et al.  Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587. , 2017, Cancer research.

[115]  S. Lorenz,et al.  Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes , 2017, Molecular Cancer.

[116]  C. Moonen,et al.  Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors. , 2017, Advanced drug delivery reviews.

[117]  Richard G. Taylor,et al.  Transcriptome profiling of antiviral immune and dietary fatty acid dependent responses of Atlantic salmon macrophage-like cells , 2017, BMC Genomics.

[118]  E. Sauter.  Exosomes in blood and cancer , 2017 .

[119]  Wei Li,et al.  Chemically Edited Exosomes with Dual Ligand Purified by Microfluidic Device for Active Targeted Drug Delivery to Tumor Cells. , 2017, ACS applied materials & interfaces.

[120]  Theodora Katsila,et al.  Exosomes: A Cancer Theranostics Road Map , 2017, Public Health Genomics.

[121]  Y. Tabata,et al.  Augmented liver targeting of exosomes by surface modification with cationized pullulan. , 2017, Acta biomaterialia.

[122]  Subbarao Bondada,et al.  Milk-derived exosomes for oral delivery of paclitaxel. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[123]  Róisín M. Dwyer,et al.  Engineering Exosomes for Cancer Therapy , 2017, International journal of molecular sciences.

[124]  Bo Li,et al.  Breast milk-derived exosomes promote intestinal epithelial cell growth. , 2017, Journal of pediatric surgery.

[125]  A. Agrawal,et al.  Exosomal formulation of anthocyanidins against multiple cancer types. , 2017, Cancer letters.

[126]  Xin Luan,et al.  Engineering exosomes as refined biological nanoplatforms for drug delivery , 2017, Acta Pharmacologica Sinica.

[127]  H. Iinuma,et al.  Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer. , 2017, Oncology letters.

[128]  Abigail Hielscher,et al.  Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting , 2017, Journal of Cancer.

[129]  Wei Zhang,et al.  Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes? , 2017, Cellular Physiology and Biochemistry.

[130]  C. Garrido,et al.  Exosomes in cancer theranostic: Diamonds in the rough , 2017, Cell adhesion & migration.

[131]  Jun Luo,et al.  miR-148a and miR-17–5p synergistically regulate milk TAG synthesis via PPARGC1A and PPARA in goat mammary epithelial cells , 2017, RNA biology.

[132]  James P K Armstrong,et al.  Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics. , 2017, ACS nano.

[133]  J. Lorente,et al.  Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection. , 2017, Methods in molecular biology.

[134]  R. Ramesh,et al.  Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells , 2016, Scientific Reports.

[135]  Xuetao Cao,et al.  Characteristics and Significance of the Pre-metastatic Niche. , 2016, Cancer cell.

[136]  R. Schiffelers,et al.  Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment. , 2016, Pharmacological research.

[137]  Vikas Ghai,et al.  Recent progress toward the use of circulating microRNAs as clinical biomarkers , 2016, Archives of Toxicology.

[138]  Myung Soo Kim,et al.  Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[139]  Raghu Kalluri,et al.  The biology and function of exosomes in cancer. , 2016, The Journal of clinical investigation.

[140]  A. Seth,et al.  MiR‐301a regulates E‐cadherin expression and is predictive of prostate cancer recurrence , 2016, The Prostate.

[141]  Venkatareddy Nadithe,et al.  Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges , 2016, Acta pharmaceutica Sinica. B.

[142]  Xin Hou,et al.  Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy. , 2016, ACS nano.

[143]  L. Gurevich,et al.  Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes , 2016, Cytotechnology.

[144]  Jongmin Park,et al.  Integrated Magneto-Electrochemical Sensor for Exosome Analysis. , 2016, ACS nano.

[145]  Z. Gu,et al.  Mesenchymal stem cell-derived exosomes facilitate nasopharyngeal carcinoma progression. , 2016, American journal of cancer research.

[146]  Pieter Vader,et al.  Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting , 2016, Journal of extracellular vesicles.

[147]  Olivier Lantz,et al.  Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC , 2015, Oncoimmunology.

[148]  S. Futaki,et al.  Receptor clustering and activation by multivalent interaction through recognition peptides presented on exosomes. , 2016, Chemical communications.

[149]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[150]  Joseph C. Sun,et al.  Natural Killer Cell Memory. , 2015, Immunity.

[151]  Jun Yao,et al.  Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth , 2015, Nature.

[152]  J. Zempleni,et al.  The Intestinal Transport of Bovine Milk Exosomes Is Mediated by Endocytosis in Human Colon Carcinoma Caco-2 Cells and Rat Small Intestinal IEC-6 Cells. , 2015, The Journal of nutrition.

[153]  Steven M Jay,et al.  Exogenous DNA Loading into Extracellular Vesicles via Electroporation is Size-Dependent and Enables Limited Gene Delivery. , 2015, Molecular pharmaceutics.

[154]  Namritha Ravinder,et al.  Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection. , 2015, Journal of biotechnology.

[155]  Samuel A Wickline,et al.  Magnetic resonance imaging of melanoma exosomes in lymph nodes , 2015, Magnetic resonance in medicine.

[156]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[157]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[158]  Sha Li,et al.  Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function , 2015, Genom. Proteom. Bioinform..

[159]  L. O’Driscoll,et al.  Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.

[160]  K. Nicholas,et al.  Differential temporal expression of milk miRNA during the lactation cycle of the marsupial tammar wallaby (Macropus eugenii) , 2014, BMC Genomics.

[161]  J. Redzic,et al.  Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro. , 2014, Biochimica et biophysica acta.

[162]  Jan Grimm,et al.  Nanoparticles for imaging: top or flop? , 2014, Radiology.

[163]  Tian-wu Chen,et al.  The Effect of Superparamagnetic Iron Oxide with iRGD Peptide on the Labeling of Pancreatic Cancer Cells In Vitro: A Preliminary Study , 2014, BioMed research international.

[164]  Weiying Zhou,et al.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. , 2014, Cancer cell.

[165]  Olivier Elemento,et al.  Double-stranded DNA in exosomes: a novel biomarker in cancer detection , 2014, Cell Research.

[166]  Jian Song,et al.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.

[167]  G. Jönsson,et al.  WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells , 2014, Molecular Cancer.

[168]  G. Schmitz,et al.  Milk: an exosomal microRNA transmitter promoting thymic regulatory T cell maturation preventing the development of atopy? , 2014, Journal of Translational Medicine.

[169]  G. Shu,et al.  Exploration of microRNAs in porcine milk exosomes , 2014, BMC Genomics.

[170]  J. Ji,et al.  Enhanced retention and cellular uptake of nanoparticles in tumors by controlling their aggregation behavior. , 2013, ACS nano.

[171]  Wei Wang,et al.  Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. , 2013, Cancer letters.

[172]  D. Mazurov,et al.  Tetraspanin protein CD9 interacts with metalloprotease CD10 and enhances its release via exosomes , 2013, The FEBS journal.

[173]  Shinobu Ueda,et al.  Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[174]  F. Chisari,et al.  Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. , 2012, Cell host & microbe.

[175]  Dan Mercola,et al.  Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate Cancer , 2012, PloS one.

[176]  Ruth S. Waterman,et al.  Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and Metastasis , 2012, PloS one.

[177]  R. Steinman.  Decisions about dendritic cells: past, present, and future. , 2012, Annual review of immunology.

[178]  B. Cookson,et al.  Membrane Vesicle Release in Bacteria, Eukaryotes, and Archaea: a Conserved yet Underappreciated Aspect of Microbial Life , 2012, Infection and Immunity.

[179]  Y. Igarashi,et al.  Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-β by Microglia , 2012, The Journal of Biological Chemistry.

[180]  Richard J Simpson,et al.  Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. , 2012, Methods.

[181]  C. Benz,et al.  Tyrosine Kinase Inhibitors Targeted to the Epidermal Growth Factor Receptor Subfamily , 2000, Drugs.

[182]  R. Pallini,et al.  Mesenchymal Stromal Cells Primed with Paclitaxel Provide a New Approach for Cancer Therapy , 2011, PloS one.

[183]  F. Su,et al.  Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells , 2011, Molecular Cancer.

[184]  T. Wurdinger,et al.  LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF‐κB activation , 2011, The EMBO journal.

[185]  N. Fukuda,et al.  Coronary vein infusion of multipotent stromal cells from bone marrow preserves cardiac function in swine ischemic cardiomyopathy via enhanced neovascularization , 2011, Laboratory Investigation.

[186]  M. Mahmoudi,et al.  Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.

[187]  Aled Clayton,et al.  Cancer exosomes trigger fibroblast to myofibroblast differentiation. , 2010, Cancer research.

[188]  R. N. Saha,et al.  Nanoparticulate drug delivery systems for cancer chemotherapy , 2010, Molecular membrane biology.

[189]  Hon-Man Liu,et al.  Homologous RBC-derived vesicles as ultrasmall carriers of iron oxide for magnetic resonance imaging of stem cells , 2010, Nanotechnology.

[190]  G. Pasterkamp,et al.  Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. , 2010, Journal of molecular and cellular cardiology.

[191]  N. Aoki,et al.  Isolation of bovine milk-derived microvesicles carrying mRNAs and microRNAs. , 2010, Biochemical and biophysical research communications.

[192]  Erkki Ruoslahti,et al.  Targeting of drugs and nanoparticles to tumors , 2010, The Journal of cell biology.

[193]  Carmen Visus,et al.  Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes1 , 2009, The Journal of Immunology.

[194]  Warren C W Chan,et al.  Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.

[195]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[196]  H. Merkle,et al.  PEGylation as a tool for the biomedical engineering of surface modified microparticles. , 2008, Journal of pharmaceutical sciences.

[197]  Petra Schwille,et al.  Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes , 2008, Science.

[198]  A. Vlahou,et al.  Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. , 2007, Stem cells and development.

[199]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[200]  Janko Kos,et al.  Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[201]  W. Grizzle,et al.  Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. , 2007, Biochimica et biophysica acta.

[202]  Trairak Pisitkun,et al.  Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. , 2007, American journal of physiology. Renal physiology.

[203]  Jim Xiang,et al.  Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T‐lymphocyte responses and antitumour immunity , 2007, Immunology.

[204]  Wei Huang,et al.  Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells , 2006, Cell biology international.

[205]  S. Gabrielsson,et al.  Direct exosome stimulation of peripheral humanT cells detected by ELISPOT , 2006, European journal of immunology.

[206]  Hermann Eichler,et al.  Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue , 2006, Stem cells.

[207]  Y. Bae,et al.  Characterization and Expression Analysis of Mesenchymal Stem Cells from Human Bone Marrow and Adipose Tissue , 2004, Cellular Physiology and Biochemistry.

[208]  H. Tsuda,et al.  Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model , 2004, Gene Therapy.

[209]  P. Low,et al.  Folate receptor-targeted drugs for cancer and inflammatory diseases. , 2004, Advanced drug delivery reviews.

[210]  O. Ringdén,et al.  Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells , 2003, Bone Marrow Transplantation.

[211]  Y. Tseng,et al.  Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. , 2002, Molecular pharmacology.

[212]  Veronica Huber,et al.  Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles , 2002, The Journal of experimental medicine.

[213]  J. Jurcic.  Antibody therapy for residual disease in acute myelogenous leukemia. , 2001, Critical reviews in oncology/hematology.

[214]  Laurence Zitvogel,et al.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes , 1998, Nature Medicine.

[215]  R K Jain,et al.  Barriers to drug delivery in solid tumors. , 1994, Scientific American.

[216]  P. Renshaw,et al.  Immunospecific NMR contrast agents. , 1986, Magnetic resonance imaging.